CHU Clermont-Ferrand
Clermont-Ferrand, France
NCT Number: NCT07786688
Dysmenorrhea is defined by the French National College of Gynecologists and Obstetricians as "cyclic abdominopelvic pain, occurring around menstruation, beginning shortly before its onset and sometimes persisting afterward." Its prevalence is difficult to determine precisely, but studies show that 16 to 90% of women in the general population experience permanent or occasional dysmenorrhea, and that more than 20% of them must limit their activities during menstruation. The origins of this pain remain poorly understood, but it is now known to be associated with significant emotional, psychological, and functional health consequences. Several studies have demonstrated that a history of violence experienced during childhood and adolescence is associated with the onset of chronic pain, but to the investigators' knowledge, no study has specifically analyzed the impact of violence on the presence of dysmenorrhea in adulthood. This study aims to administer a questionnaire assessing dysmenorrhea and history of violence (Childhood Trauma Questionnaire, short French version - CTQ) to patients consulting the Gynecology Department of Estaing University Hospital for menstrual pain (dysmenorrhea). The investigators aim to identify an association between the presence of dysmenorrhea and a history of violence during childhood.
Interested in participating?
Request Info18 year–53 year
Female
Interventional
Not applicable
Clermont-Ferrand, France
The short version of the CTQ is a questionnaire comprising five subscales of maltreatment (emotional and physical neglect, sexual, physical, and emotional abuse), validated by several international studies and in the French-speaking population. The study will be offered to patients consulting the Gynecology Department of Estaing University Hospital for dysmenorrhea. An information sheet will be given to them at the end of the consultation. Participants will be contacted by phone within 48 business hours following the consultation to provide additional explanations about the study. These calls will be recorded in the patient's medical file. An email will then be sent containing a link to access the short version of the CTQ questionnaire, along with a consent form. By offering participants the opportunity to answer intimate questions outside the consultation setting, for example at home or in a place where they feel safe and comfortable, more authentic and relevant responses are expected. A reminder email will be sent to patients who have not responded to the online questionnaire on days 5, 10, and 15. Patients whose score corresponds to a history of maltreatment will be offered an appointment within a maximum of 15 days with a gynecologist specialized in victimology, in order to provide the care best suited to their needs (assessment, explanations, legal or psychological support procedures, referral to support associations, targeted gynecological follow-up). The patient will be contacted again 3 months later (in person or by phone) to assess treatment efficacy and satisfaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We propose a medical appointment to all the women with a positive score at the CTQ short version
Other names: Appointment in a specific service
Time frame: Day 15, at 3 months
The prevalence (percentage) of childhood abuse in a population of women suffering from dysmenorrhea.
Time frame: Day 15, at 3 months
The prevalence (percentage) of different forms of violence (sexual, physical or emotional) during childhood in a population of women suffering from dysmenorrhea
Time frame: 15 jours
Classification of dysmenorrhea as primary (functional, in the absence of identifiable pelvic pathology) or secondary (organic, in the presence of a documented gynecological condition recorded in the medical file: endometriosis, adenomyosis, uterine fibroids, ovarian cyst, uterine malformation, history of salpingitis). The distribution between the two forms will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment.
Time frame: Day 15
Analgesic consumption recorded from the medical file, classified according to the WHO analgesic ladder (step I, II, or III), along with the maximum number of daily doses. The proportion of exposed patients will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse).
Time frame: Day 15
Contraceptive method recorded from the medical file (none, oral contraception, intrauterine device, implant, patch, vaginal ring, condoms, tubal ligation, vasectomy). The proportion of patients by contraceptive type will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse)
Time frame: Day 15
Intensity of menstrual pain assessed using a Visual Analogue Scale (VAS), scored from 0 (no pain) to 10 (worst pain imaginable). Mean VAS scores will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse), as well as by the cumulative number of forms of childhood violence experienced.
Time frame: At 3 months
3 months later, is the patient satisfied with the medical care proposed in victimology : YES or NO ?
University Hospital, Clermont-Ferrand
Other
Acronym: LADY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07424859
Chronic Pain, Dysmenorrhea
São Paulo, Brazil
View Trial DetailsNCT06353789
Chronic Pain, Dysmenorrhea
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT02214550
Brain Diseases, Central Nervous System Diseases
Evanston, Illinois, United States
View Trial DetailsNCT07011875
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Karabük, Karabük Province, Turkey (Türkiye)
View Trial Details